FactaeThe Factual News

Europe approves upadacitinib for vitiligo and severe alopecia

The European Medicines Agency approves upadacitinib for non-segmental vitiligo and severe alopecia areata.

Published 2h1 sourceNotable
Lire en français
19s

The fact

The treatment targets adults and adolescents aged 12 and over who have failed other therapies.

It provides an alternative to existing treatments, often limited in effectiveness.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
Follow topic →
Auto-synthesis from 1 media source · identified on September 24, 2026
Back to home
Discover

Read more

All sante →